Obesity is associated with worse RA outcomes and reduced effectiveness of some biologic medications
With the effects seen of the GLP-1 family of drugs on preventing kidney damage in diabetes, liver disease (non-alcoholic or metabolic-associated steatosis, NASH/MASH), and addiction, this drug class is exceeding all expectations
2007, titled Insomnia, serotonin and depression, of 100 healthy volunteers (50% male, 50% female) found significant links between serotonin dysregulation and sleep disturbances, with 85% of participants reporting sleep issues
PlexusDx supports this structured monitoring approach, helping patients and their clinicians recognize when therapeutic targets have been met or when additional interventions are needed
The nausea that dictated evening dosing during your first month may virtually disappear by month three
In other words, no harmful interactions are known at normal doses